Washington Capital Management Inc. Increases Stock Holdings in Humana Inc. (NYSE:HUM)

Washington Capital Management Inc. lifted its stake in shares of Humana Inc. (NYSE:HUM) by 23.5% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,100 shares of the insurance provider’s stock after buying an additional 400 shares during the quarter. Washington Capital Management Inc.’s holdings in Humana were worth $556,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of HUM. Revolve Wealth Partners LLC purchased a new stake in shares of Humana during the 4th quarter valued at about $202,000. Mather Group LLC. raised its holdings in shares of Humana by 21.0% during the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider’s stock valued at $60,000 after buying an additional 41 shares during the period. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Humana by 6.3% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 17,567 shares of the insurance provider’s stock valued at $4,481,000 after buying an additional 1,039 shares during the period. Choreo LLC raised its holdings in shares of Humana by 17.4% during the 4th quarter. Choreo LLC now owns 6,711 shares of the insurance provider’s stock valued at $1,706,000 after buying an additional 995 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Humana by 1.7% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 330,906 shares of the insurance provider’s stock valued at $83,954,000 after buying an additional 5,497 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

HUM has been the topic of several analyst reports. Morgan Stanley dropped their price objective on Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 12th. Barclays dropped their price objective on Humana from $322.00 to $273.00 and set an “equal weight” rating on the stock in a report on Monday, June 2nd. Robert W. Baird lifted their price objective on Humana from $270.00 to $300.00 and gave the stock a “neutral” rating in a report on Tuesday, April 15th. Guggenheim initiated coverage on Humana in a report on Wednesday, April 9th. They set a “buy” rating and a $326.00 price objective on the stock. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $290.00 price objective on shares of Humana in a report on Thursday, May 1st. Sixteen research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat.com, Humana presently has a consensus rating of “Hold” and an average target price of $284.48.

Humana Price Performance

Shares of HUM opened at $230.36 on Friday. The firm has a market cap of $27.80 billion, a price-to-earnings ratio of 23.15, a PEG ratio of 2.05 and a beta of 0.43. The stock has a 50 day moving average of $253.49 and a 200-day moving average of $264.91. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 52 week low of $212.45 and a 52 week high of $406.46.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, topping the consensus estimate of $10.07 by $1.51. The company had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. Humana had a return on equity of 11.70% and a net margin of 1.02%. The business’s revenue was up 8.4% on a year-over-year basis. During the same quarter last year, the firm earned $7.23 EPS. As a group, analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.54%. Humana’s dividend payout ratio is currently 25.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.